MAPK phosphatases as novel targets for rheumatoid arthritis

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
MAPK phosphatases as novel targets for rheumatoid arthritis
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


Expert Opinion on Therapeutic Targets , July 2008, Vol. 12, No. 7, Pages 795-808.
<br/>
Background: Rheumatoid arthritis (RA) represents a challenge for therapeutic interventions due to complex inflammatory signalling pathways underlying its pathogenesis. The MAPK signalling network, a major effector limb of the inflammatory lesion, is an ...

Read more...

Source: Expert Opinion: Expert Opinion on Therapeutic Targets: Table of Contents
Table of Contents for Expert Opinion on Therapeutic Targets. List of articles from both the latest and ahead of print issues.
View user's profileSend private message
MAPK phosphatases as novel targets for rheumatoid arthritis
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map